1-BUTYL-8-[4-[(4-ETHYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
Compound with spectra: 1 NMR
![1-BUTYL-8-[4-[(4-ETHYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE](/api/compound/D3vpSDgoKRF.png?ph=true&h=300&w=458 "1-BUTYL-8-[4-[(4-ETHYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE")
| SpectraBase Compound ID | D3vpSDgoKRF |
|---|---|
| InChI | InChI=1S/C23H30N6O4/c1-3-5-10-29-22(31)19-21(26-23(29)32)25-20(24-19)16-6-8-17(9-7-16)33-15-18(30)28-13-11-27(4-2)12-14-28/h6-9H,3-5,10-15H2,1-2H3,(H,24,25)(H,26,32) |
| InChIKey | GXXUBSFHBWUPBT-UHFFFAOYSA-N |
| Mol Weight | 454.53 g/mol |
| Molecular Formula | C23H30N6O4 |
| Exact Mass | 454.232853 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1,3-Dimethyl-8-(4-phenylphenyl)-7H-purine-2,6-dione
6-Methyl-3-(2-methylphenyl)-5H,6H,7H,8H-pyrimido[5,4-e][1,2,4]triazine-5,7-dione
5,6,7,8-TETRAHYDRO-3-(PARA-NITROPHENYL)-6,8-DIMETHYLPYRIMIDO[5,4-E][1,2,4]-TRIAZIN-5,7-DIONE
3-(4-Fluorophenyl)-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(6H,8H)-dione
8-{[4-(2-fluorophenyl)-1-piperazinyl]methyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
8-{[4-(4-methoxyphenyl)-1-piperazinyl]methyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Pyrimido[5,4-e]-1,2,4-triazine-5,7(6H,8H)-dione,6,8-dimethyl-3-(3-thienyl)-
8-{[4-(3-chlorophenyl)-1-piperazinyl]methyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
1-Methyl-3-(4-hydroxy-4-hexehyl)-5-methyl-imidazo[4,5-e]1,3-diazin-2,4-dione
8-{[4-(4-fluorophenyl)-1-piperazinyl]methyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
| Title | Journal or Book | Year |
|---|---|---|
| 1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists | Journal of Medicinal Chemistry | 2002 |